Data and Information

Can Genetic Data End Trial-and-Error Prescribing?
Data and Information Can Genetic Data End Trial-and-Error Prescribing?

For decades, the medical community has grappled with the inherent unpredictability of how different human bodies metabolize powerful medications, often leading to a cycle of trial and error that jeopardizes patient safety. Xact Laboratories has recently secured a transformative patent that marks a

FMC Health Reaches $2.15 Million Data Breach Settlement
Data and Information FMC Health Reaches $2.15 Million Data Breach Settlement

The vulnerability of patient health information has never been more apparent than in the recent resolution of a massive class-action lawsuit involving FMC Health and thousands of affected individuals across the country. This settlement, totaling approximately $2.15 million, serves as a stark

Sofya Empowers Doctors with Programmable Clinical AI
Data and Information Sofya Empowers Doctors with Programmable Clinical AI

The administrative burden weighing down the American healthcare system has reached a critical tipping point where physicians often spend more time navigating digital interfaces than engaging in direct patient care. Sofya emerged as a transformative force in this landscape, providing a programmable

Sanford Health Scales Responsible AI to Improve Patient Care
Data and Information Sanford Health Scales Responsible AI to Improve Patient Care

The sheer volume of medical data generated every second in a modern clinical setting has reached a point where manual interpretation alone can no longer ensure the highest standards of personalized medicine without the aid of sophisticated computational tools. Sanford Health is navigating this

Top Healthcare Analytics Software Leads the 2026 Shortlist
Data and Information Top Healthcare Analytics Software Leads the 2026 Shortlist

The modern healthcare environment has reached a critical inflection point where the sheer volume of generated data frequently outpaces the human capacity to interpret and act upon it effectively. As organizations navigate the complexities of modern medicine, the focus has shifted from the mere

FDA Approves FoundationOne CDx for Tepotinib in MET+ NSCLC
Data and Information FDA Approves FoundationOne CDx for Tepotinib in MET+ NSCLC

The landscape of oncology is shifting rapidly as physicians move away from broad-spectrum chemotherapy toward precision interventions that target the specific genetic drivers of a patient's unique tumor profile. Recent data indicates that approximately three to four percent of patients with

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later